SNP Chromosome Microarray as an Alternative Assessment of Breast Cancers Equivocal for HER2 by FISH

被引：0
|
作者：
Dillon, J. L. [1 ]
Marotti, J. D. [1 ]
Jung, H. [1 ]
Lefferts, J. A. [1 ]
Tafe, L. J. [1 ]
机构：
[1] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2016年 / 18卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
S85
引用
收藏
页码：1018 / 1018
页数：1
相关论文
共 50 条
  • [1] Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification
    Agersborg, Sally
    Mixon, Christopher
    Thanh Nguyen
    Aithal, Sramila
    Sudarsanam, Sucha
    Blocker, Forrest
    Weiss, Lawrence
    Gasparini, Robert
    Jiang, Shiping
    Chen, Wayne
    Hess, Gregory
    Albitar, Maher
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 170 (02) : 321 - 328
  • [2] Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification
    Agersborg, Sally
    Mixon, Christopher
    Thanh Nguyen
    Aithal, Sramila
    Blocker, Forrest
    Weiss, Lawrence
    Gasparini, Robert
    Jiang, Shiping
    Chen, Wayne
    Hess, Gregory
    Albitar, Maher
    CANCER RESEARCH, 2018, 78 (13)
  • [3] Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification
    Sally Agersborg
    Christopher Mixon
    Thanh Nguyen
    Sramila Aithal
    Sucha Sudarsanam
    Forrest Blocker
    Lawrence Weiss
    Robert Gasparini
    Shiping Jiang
    Wayne Chen
    Gregory Hess
    Maher Albitar
    Breast Cancer Research and Treatment, 2018, 170 : 321 - 328
  • [4] HER2 equivocal breast cancer that is positive by alternative probe HER2 FISH are classified as HER2 negative by Oncotype DX
    Tozbikian, Gary H.
    Zynger, Debra L.
    BREAST JOURNAL, 2018, 24 (04): : 535 - 540
  • [5] Characteristics of HER2 FISH-Equivocal Breast Cancers and the Impacts on HER2 Status of 2018 ASCO/CAP Guideline
    Kong, Hui
    Bai, Qianming
    Lu, Hongfen
    Zhou, Xiaoyan
    Yang, Wentao
    LABORATORY INVESTIGATION, 2019, 99
  • [6] HER2 FISH classification of equivocal HER2 IHC breast cancers with use of the 2013 ASCO/CAP practice guideline
    Yao-Shan Fan
    Carmen E. Casas
    Jinghong Peng
    Melanie Watkins
    Lynn Fan
    Jennifer Chapman
    Offiong Francis Ikpatt
    Carmen Gomez
    Wei Zhao
    Isildinha M. Reis
    Breast Cancer Research and Treatment, 2016, 155 : 457 - 462
  • [7] HER2 FISH classification of equivocal HER2 IHC breast cancers with use of the 2013 ASCO/CAP practice guideline
    Fan, Yao-Shan
    Casas, Carmen E.
    Peng, Jinghong
    Watkins, Melanie
    Fan, Lynn
    Chapman, Jennifer
    Ikpatt, Offiong Francis
    Gomez, Carmen
    Zhao, Wei
    Reis, Isildinha M.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 155 (03) : 457 - 462
  • [8] Characteristics of HER2 FISH-Equivocal Breast Cancers and the Impacts on HER2 Status of 2018 ASCO/CAP Guideline
    Kong, Hui
    Bai, Qianming
    Lu, Hongfen
    Zhou, Xiaoyan
    Yang, Wentao
    MODERN PATHOLOGY, 2019, 32
  • [9] HER2 FISH results in breast cancers with increased CEN17 signals using alternative chromosome 17 probes - reclassifying cases in the equivocal category
    Holzschuh, Maria-Anna
    Czyz, Zbigniew
    Hauke, Sven
    Inwald, Elisabeth C.
    Polzer, Bernhard
    Brockhoff, Gero
    HISTOPATHOLOGY, 2017, 71 (04) : 610 - 625
  • [10] FISH and HER2/neu equivocal immunohistochemistry in breast carcinoma
    Okaly, Geeta Vikram Patil
    Panwar, Dipti
    Lingappa, Kavitha Bidadli
    Kumari, Prasanna
    Anand, Abhishek
    Kumar, Prashantha
    Chikkalingaiah, Manju Hosur
    Kumar, Rekha Vijay
    INDIAN JOURNAL OF CANCER, 2019, 56 (02) : 119 - 123
12345